2 completed, 1 active not recruiting. 2 Phase 3, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
| Not applicable | 1 | Active not recruiting 1 |
Follow Comprehensive Support Project for Oncology Research: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Patient Reported Outcomes Study Using Electronic Monitoring System for Advanced or Metastatic Solid Cancer e-PRO monitoring - Breast Cancer, Lung Cancer | Not applicable | Active not recruiting | Comprehensive Support Project for Oncology Research | 500 | 2021-01-26 | 2024-04-23 |
| Evaluation of Oral Care to Prevent Oral Mucositis in ER Positive MBC Patients Treated With Everolimus: Phase 3 RCT Oral management, Everolimus - Breast Cancer | Phase 3 | Completed | Comprehensive Support Project for Oncology Research | 174 | 2015-03-26 | 2019-10-21 |
| National Surgical Adjuvant Study of Breast Cancer(N-SAS BC) 07 [RESPECT] trastuzumab monotherapy, trastuzumab and chemotherapy - Breast Cancer | Phase 3 | Completed | Comprehensive Support Project for Oncology Research | 275 | 2009-10-28 | 2019-10-21 |
Breast Neoplasms (3) · Colorectal Neoplasms (1) · Endometrial Neoplasms (1) · Liver Neoplasms (1) · Lung Neoplasms (1) · Ovarian Neoplasms (1) · Squamous Cell Carcinoma of Head and Neck (1) · Stomach Neoplasms (1)
Carboplatin (1) · Drug Therapy (1) · Everolimus (1) · Therapeutics (1) · Trastuzumab (1)
Japan (3)
Akira Yamao (1) · Hironobu Minami (1) · Masataka Sawaki (1)
PMID 32936713, PMID 33413212, PMID 33835842, PMID 34080094, PMID 41188218